Advertisement

Entzündliche Myopathien

  • J. M. Schröder

Zusammenfassung

Unter den entzündlichen Erkrankungen der Skelettmuskulatur sind die infektiösen, durch Viren, Bakterien, Parasiten und andere Erreger bedingten von den wesentlich häufigeren, offenkundig nichtinfektiösen, im Rahmen von Autoaggressionskrankheiten oder anderen immunogenetischen Erkrankungen auftretenden Prozessen zu unterscheiden (Polymyositis, Einschlusskörpermyositis und Dermatomyositis; interstitielle Myositiden bei Vaskulitiden, Gefäßbindegewebserkrankungen bzw. Kollagenosen; fokale Myositis, Myositis orbitalis, eosinophile Myositis, Polymyalgia rheumatica u.a.).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adams R D (1975) Diseases of muscle. A study in pathology, 3rd edn. Harper & Row, New YorkGoogle Scholar
  2. Alex O, Wiethege T, Müller K M (1998) Myositis proliferans: a pseudosarcomatous lesion in soft tissue. Pathologe 19: 308–312PubMedCrossRefGoogle Scholar
  3. Amemiya K, Granger R P, Dalakas M C (2000) Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time: studies in repeated muscle biopsies. Brain 123: 2030–2039PubMedCrossRefGoogle Scholar
  4. Askanas V, Engel W K (1998) Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis. Curr Opin Rheumatol 10: 530–542PubMedCrossRefGoogle Scholar
  5. Askanas V, Engel W K, Alvarez R B, Frangione B, Ghiso J, Vidal R (2000) Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Vall22Ile allele. Ann Neurol 47: 544–549PubMedCrossRefGoogle Scholar
  6. Banker B Q (1975) Dermatomyostis of childhood, ultrastructural alteratious of muscle and intramuscular blood vessels. J Neuropathol Exp Neurol 34: 46–75PubMedCrossRefGoogle Scholar
  7. Bartz-Bazzanella P, Genth E, Pollmann H J, Schröder J M, Volker A (1992) Eosinophilie-Myalgia-Syndrome mit Fasziitis und interstitieller Myositis nach L-Tryptophan-Einnahme (see comments). Z Rheumatol 51: 3–13PubMedGoogle Scholar
  8. Bäumli H P, Mumenthaler M (1977) The perifascicular atrophy factor. An aid in the histological diagnosis of polymyositis. J Neurol 214: 129–136Google Scholar
  9. Carpenter S (1996) Inclusion body myositis, a review. J Neuropathol Exp Neurol 55: 1105–1114PubMedCrossRefGoogle Scholar
  10. Carpenter S, Karpati G, Heller I, Eisen A (1978) Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 28: 8–17PubMedGoogle Scholar
  11. Chou S M (1967) Myxovirus-like structures in a case of human chronic polymyositis. Science 158: 1453–1455PubMedCrossRefGoogle Scholar
  12. Cornford M E, Ho H W, Vinters H V (1992) Correlation of neuromuscular pathology in acquired immune deficiency syndrome patients with cytomegalovirus infection and zidovudine treatment. Acta Neuropathol 84: 516–529PubMedCrossRefGoogle Scholar
  13. Davis M J, Cilo M, Plaitakis A, Yahr M D (1976) Trichinosis: severe myopathic involvement with recovery. Neurology 26: 37–40PubMedGoogle Scholar
  14. Dawkins R L (1965) Experimental myositis associated with hypersensitivity to muscle. J Pathol Bacteriol 90: 619–625PubMedCrossRefGoogle Scholar
  15. De Bleecker J L, Meire V I, Van Walleghem I E, Groessens I M, Schröder J M (2001) Immunolocalization of FAS and FAS ligand in inflammatory myopathies. Acta Nerupathol (Berl) 101: 572–578Google Scholar
  16. Dickoff D J, Simpson D M, Wiley C A, Mendelson S G, Farraye J, Wolfe D E, Wachsman W (1993) HTLV-1 in acquired adult myopathy. Muscle Nerve 16: 162–165PubMedCrossRefGoogle Scholar
  17. Dieler R, Schröder J M (1990) Lacunar dilatations of intrafusal and extrafusal terminal cisternae, annulate lamellae, confronting cisternae and tubulofilamentous inclusions within the spectrum of muscle and nerve fiber changes in myotonic dystrophy. Pathol Res Pract 186: 371–382PubMedGoogle Scholar
  18. Dubowitz V, Brooke, M H (1973) Muscle biopsy: a modern approach. Saunders, PhiladelphiaCrossRefGoogle Scholar
  19. Fidzianska A (1973) Virus-like structures in muscle in chronic polymyositis. Acta Neuropathol 23: 23–31Google Scholar
  20. Fujii K, Moriya Y, Fujita S, Akasu T, Miyake H, Nakanishi Y, Saito T (2000) Dermatomyositis accompanied by rectal cancer: report of a case. Surg Today 30: 302–304PubMedCrossRefGoogle Scholar
  21. Fukuhara N (1979) Electron microscopical demonstration of nucleic acids in virus-like particles in the skeletal muscle of a traffic accident victim. Acta Neuropathol (Berl) 47: 55–59CrossRefGoogle Scholar
  22. Genth E, Kaufmann S, Schröder J M, Hartl P W (1985) Zum Krankheitsbild der juvenilen Dermatomyositis. medwelt 36: 1302–1311Google Scholar
  23. Haas D C, Arnason B G (1974) Cell-mediated immunity in polymyositis. Creatine phosphokinase release from muscle cultures. Arch Neurol 31: 192–196Google Scholar
  24. Heffner R R Jr, Barron S A (1980) Denervating changes in focal myositis, a benign inflammatory pseudotumor. Arch Pathol Lab Med 104: 261–264PubMedGoogle Scholar
  25. Heffner R R Jr, Barron S A (1981) Polymyositis beginning as a focal process. Arch Neurol 38: 439–442PubMedGoogle Scholar
  26. Heffner R R Jr, Armbrustmacher V W, Earle K M (1977) Focal myositis. Cancer 40: 301–306Google Scholar
  27. Hermanns B, Molnar M, Schröder J M (2000) Peripheral neuropathy associated with hereditary and sporadic inclusion body myositis: confirmation by electron microscopy and morphometry. J Neurol Sei 179: 92–102CrossRefGoogle Scholar
  28. Hewlett R H, Brownell B (1975) Granulomatous myopathy: its relationship to sarcoidosis and polymyositis. J Neurol Neurosurg Psychiatry 38: 1090–1099PubMedCrossRefGoogle Scholar
  29. Higuchi I, Niiyama T, Uchida Y et al. (2000) Microvascular endothelial abnormality in skeletal muscle from a patient with gastric cancer without dermatomyositis. Acta Neuropathol (Berl) 100: 718–722CrossRefGoogle Scholar
  30. Isaacson G, Chan K H, Heffner R R Jr (1991) Focal myositis. A new cause for the pediatric neck mass. Arch Otolaryngol Head Neck Surg 117: 103–105Google Scholar
  31. Kakulas B A (1966) Destruction of differentiated muscle cultures by sensitised lymphoid cells. J Pathol Bacteriol 91: 495–503PubMedCrossRefGoogle Scholar
  32. Koffman B M, Rugiero M, Dalakas M C (1998a) Immune- mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve 21: 115–117PubMedCrossRefGoogle Scholar
  33. Koffman B M, Sivakumar K, Simonis T, Stroncek D, Dalakas M C (1998b) HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies. J Neuroimmunol 84: 139–142PubMedCrossRefGoogle Scholar
  34. Kurup A, Yew W S, San L M, Ang B, Lim S, Tai G K (2000) Outbreak of suspected trichinosis among travelers returning from a neighboring island. J Travel Med 7: 189–193PubMedCrossRefGoogle Scholar
  35. Liang Y, Inukai A, Kuru S, Kato T, Doyu M, Sobue G (2000) The role of lymphotoxin in pathogenesis of polymyositis. Acta Neuropathol (Berl) 100: 521–527CrossRefGoogle Scholar
  36. Love L A, Leff R L, Fräser D D, Targoff I N, Dalakas M, Plötz P H, Miller F W (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70: 360–374Google Scholar
  37. Matsubara S, Shima T, Takamori M (1993) Experimental allergic myositis in SJL/J mice immunized with rabbit myosin B fraction: immunohistochemical analysis and transfer. Acta Neuropathol 85: 138–144PubMedCrossRefGoogle Scholar
  38. Miller FW, Love LA, Barbieri SA, Balow JE, Plotz PH (1990) Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups. Clin Exp Immunol 81: 373–379PubMedCrossRefGoogle Scholar
  39. Molnar M, Schröder J M (1998) Pleomorphic mitochondrial and different filamentous inclusions in inflammatory myopathies associated with mtDNA deletions. Acta Neuro- pathol (Berl) 96: 41–51CrossRefGoogle Scholar
  40. Oldfors A, Moslemi A R, Fyhr I M, Holme E, Larsson N G, Lindberg C (1995) Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol 54: 581–587PubMedCrossRefGoogle Scholar
  41. Peng A, Koffman B M, Malley J D, Dalakas M C (2000) Disease progression in sporadic inclusion body myositis: observations in 78 patients. Neurology 55: 296–298PubMedGoogle Scholar
  42. Peter H H (1991) Vasculitiden. In: Gerok W, Hartmann F, Schustger H P (Hrsg) Klinische Immunologie. Urban 8c Schwarzenberg, München ( Innere Medizin der Gegenwart, Bd 9 )Google Scholar
  43. Plamondon S, Dent PB (2000) Juvenile amyopathic dermatomyositis: results of a case finding descriptive survey. J Rheumatol 27: 2031–2034PubMedGoogle Scholar
  44. Schröder J M (1982) Pathologie der Muskulatur. Springer, Berlin Heidelberg New YorkGoogle Scholar
  45. Schröder JM, Molnar M (1997) Mitochondrial abnormalities and peripheral neuropathy in inflammatory myopathy, especially inclusion body myositis. Mol Cell Biochem 174: 277–281PubMedCrossRefGoogle Scholar
  46. Schröder J M, Bertram M, Schnabel R, Pfaff U (1992) Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine. Acta Neuropathol 85: 39–47PubMedCrossRefGoogle Scholar
  47. Stiller D, Katenkamp D (1975) The subcutaneous fascial analogue of myositis proliferans: electron microscopic examination of two cases and comparison with myositis ossificans localisata. Virchows Arch A 368: 361–371Google Scholar
  48. Stumpf J, Kaduk B, Undeutsch K, Landgraf H, Gofferje H (1978) Trichinose: Epidemiologie, Klinik und Diagnose. Dtsch Med Wochenschr 103: 1556–1558, 1561–1562CrossRefGoogle Scholar
  49. Wirman J A (1976) Nodular fasciitis, a lesion of myofibroblasts: an ultrastructural study. Cancer 38: 2378–2389PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • J. M. Schröder

There are no affiliations available

Personalised recommendations